| Name: | Anidulafungin Echinocandin B Impurity |
| Catalogue No. | VL6570006 |
| CAS No. | 54651-05-7 |
| Molecular Formula | C52H81N7O16 |
| Molecular Weight | 1060.24 g/mol |
| Status | In-Stock |
| IUPAC Name | Cyclo[L-Thr-[(3S,4S)-3-hydroxy-4-methyl-L-Pro-]-[(4R,5R)-4,5-dihydroxy-N2-[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]-L-Orn*-]-L-Thr-L-t4Hyp-[(3S,4S)-3,4-dihydroxy-4-(4-hydroxyphenyl)-L-Abu-]]�; |
| Description | Anidulafungin Echinocandin B Impurity (cas no.-54651-05-7) or Cyclo[L-Thr-[(3S,4S)-3-hydroxy-4-methyl-L-Pro-]-[(4R,5R)-4,5-dihydroxy-N2-[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]-L-Orn*-]-L-Thr-L-t4Hyp-[(3S,4S)-3,4-dihydroxy-4-(4-hydroxyphenyl)-L-Abu-] is an impurity of anidulafungin are showing a broad spectrum of activity against all Candida species. it inhibits β-(1,3)-glucan synthesis in the fungal cell wall. |
| References | Kofla, G, and M Ruhnke. “Pharmacology and Metabolism of Anidulafungin, Caspofungin and Micafungin in the Treatment of Invasive Candidosis - Review of the Literature.” European Journal of Medical Research, vol. 16, no. 4, 28 Apr. 2011, pp. 159–166, www.ncbi.nlm.nih.gov/pmc/articles/PMC3352072/#:~:text=Echinocandins%20are%20cyclic%20lipopeptide%20molecules, 10.1186/2047-783X-16-4-159. Accessed 8 June 2020. |
